Labcorp Holdings LH Biopharma Laboratory Services — Supplies Expense

Other segment segments

Similar metrics at other companies

TMOLaboratory Products and Biopharma Services — Selling, general and administrative expenses

$597M+1.5%

TMOLaboratory Products and Biopharma Services — Cost of revenues

$4.76B+7.9%

TMOLaboratory Products and Biopharma Services — Purchases of property, plant and equipment

$259M+26.3%

AMP

AMPHPharmaceutical Products — Materials And Supplies Expense

$12.74M+21.6%

PFEBiopharma — Selling, informational and administrative expenses

$2.13B-2.5%

CYRXLife Sciences Services — Labor And Related Expense

$14.86M+13.9%

Questions, answered.

What is Labcorp Holdings's biopharma laboratory services — supplies expense?

Labcorp Holdings (LH) reported biopharma laboratory services — supplies expense of $121.5M in Q1 2026.

How has Labcorp Holdings's biopharma laboratory services — supplies expense changed year-over-year?

Labcorp Holdings's biopharma laboratory services — supplies expense increased by 9.4% year-over-year, from $111.1M to $121.5M.

What is the long-term trend for Labcorp Holdings's biopharma laboratory services — supplies expense?

Over 3 years (2022 to 2025), Labcorp Holdings's biopharma laboratory services — supplies expense has grown at a 1.3% compound annual growth rate (CAGR), from $460.6M to $478.5M.

What does biopharma laboratory services — supplies expense mean?

This represents the costs of materials, reagents, and other consumables required to perform laboratory tests and services within the Biopharma Laboratory Services segment. It is a direct variable cost tied to testing volume.